Close Menu

NEW YORK — Ceres Nanosciences said Monday that it has been awarded a $224,750 grant from the National Institutes of Health to develop technology to enhance the detection of fentanyl in urine and oral fluids.

With the funding, Ceres said it will evaluate its Nanotrap technology, which uses hydrogel nanoparticles functionalized with internal affinity baits to enrich target analytes for downstream analysis, for enriching fentanyl and its derivatives in samples prior to testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.